PubMed:10336989 / 414-622 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":208},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":208},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T29","span":{"begin":35,"end":43},"obj":"FMAID:83376"},{"id":"_T30","span":{"begin":35,"end":43},"obj":"FMAID:197661"},{"id":"_T31","span":{"begin":62,"end":68},"obj":"FMAID:97486"},{"id":"_T32","span":{"begin":62,"end":68},"obj":"FMAID:9601"},{"id":"_T33","span":{"begin":169,"end":194},"obj":"FMAID:67269"},{"id":"_T34","span":{"begin":169,"end":194},"obj":"FMAID:165262"},{"id":"_T35","span":{"begin":176,"end":194},"obj":"FMAID:199971"},{"id":"_T36","span":{"begin":176,"end":194},"obj":"FMAID:85546"},{"id":"_T37","span":{"begin":176,"end":194},"obj":"FMAID:67656"},{"id":"_T38","span":{"begin":176,"end":194},"obj":"FMAID:199169"},{"id":"_T39","span":{"begin":176,"end":194},"obj":"FMAID:63187"},{"id":"_T40","span":{"begin":176,"end":194},"obj":"FMAID:167581"},{"id":"_T41","span":{"begin":176,"end":194},"obj":"FMAID:165573"},{"id":"_T42","span":{"begin":176,"end":194},"obj":"FMAID:199168"},{"id":"_T43","span":{"begin":179,"end":185},"obj":"FMAID:162307"},{"id":"_T44","span":{"begin":179,"end":194},"obj":"FMAID:162306"},{"id":"_T45","span":{"begin":179,"end":194},"obj":"FMAID:166047"},{"id":"_T46","span":{"begin":179,"end":194},"obj":"FMAID:63841"},{"id":"_T47","span":{"begin":179,"end":194},"obj":"FMAID:164993"},{"id":"_T48","span":{"begin":179,"end":194},"obj":"FMAID:66843"},{"id":"_T49","span":{"begin":179,"end":194},"obj":"FMAID:210691"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"uniprot-human","denotations":[{"id":"T8","span":{"begin":35,"end":52},"obj":"http://www.uniprot.org/uniprot/P03372"},{"id":"T9","span":{"begin":62,"end":80},"obj":"http://www.uniprot.org/uniprot/Q8IZY5"},{"id":"T10","span":{"begin":136,"end":138},"obj":"http://www.uniprot.org/uniprot/O94907"},{"id":"T12","span":{"begin":136,"end":138},"obj":"http://www.uniprot.org/uniprot/Q92952"},{"id":"T14","span":{"begin":139,"end":142},"obj":"http://www.uniprot.org/uniprot/P61006"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":35,"end":52},"obj":"http://www.uniprot.org/uniprot/P19785"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T5","span":{"begin":69,"end":75},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"},{"id":"T6","span":{"begin":117,"end":125},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/45308"},{"id":"T7","span":{"begin":117,"end":125},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/1369386"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"GO-CC","denotations":[{"id":"T11","span":{"begin":76,"end":80},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T12","span":{"begin":126,"end":130},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T25","span":{"begin":179,"end":194},"obj":"http://purl.obolibrary.org/obo/GO_0005886"},{"id":"T28","span":{"begin":186,"end":194},"obj":"http://purl.obolibrary.org/obo/GO_0016020"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"UBERON-AE","denotations":[{"id":"T3","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"EDAM-topics","denotations":[{"id":"T5","span":{"begin":69,"end":75},"obj":"http://edamontology.org/topic_2640"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"EDAM-DFO","denotations":[{"id":"T2","span":{"begin":101,"end":111},"obj":"http://edamontology.org/operation_2424"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T3","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"PubmedHPO","denotations":[{"id":"T4","span":{"begin":62,"end":75},"obj":"HP_0003002"},{"id":"T5","span":{"begin":62,"end":75},"obj":"HP_0100013"},{"id":"T6","span":{"begin":69,"end":75},"obj":"HP_0002664"},{"id":"T7","span":{"begin":117,"end":125},"obj":"HP_0002861"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":35,"end":75},"obj":"Disease"},{"id":"T4","span":{"begin":117,"end":125},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0006513"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005105"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"HP-phenotype","denotations":[{"id":"T3","span":{"begin":62,"end":75},"obj":"Phenotype"},{"id":"T4","span":{"begin":117,"end":125},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0003002"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0002861"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T5","span":{"begin":62,"end":68},"obj":"Body_part"},{"id":"T6","span":{"begin":179,"end":194},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/GO_0005886"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}

{"project":"CL-cell","denotations":[{"id":"T3","span":{"begin":69,"end":80},"obj":"Cell"}],"attributes":[{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0001064"}],"text":"The analyses were performed on the estrogen receptor-negative breast cancer cell line MDA231 and, in comparison, the melanoma cell line SK-MEL-2, which expresses a high number of plasma membrane-bound IGF-1R."}